Zusammenfassung
In Deutschland sind ca. 100–150 Patienten pro 100 000 Einwohner von der Multiplen Sklerose (MS) betroffen. Pro Jahr erkranken ca. 3000–5000 Patienten neu. Pathologisch anatomisch betrifft die MS zwar bevorzugt periventrikuläres Marklager, Sehnerv, Pons und zervikales Myelon, im Prinzip kann sie aber jede Struktur des zentralen Nervensystems (ZNS) befallen. Die Verteilung der Herde folgt keinem systematischen Muster, auch wenn es „typische“ Konstellationen gibt. Aus dieser Besonderheit resultiert die große Variabilität der klinischen Symptomatik. Nahezu jedes denkbare Symptom des ZNS kann auch im Rahmen der MS auftreten. Neben der Variabilität der Lokalisation der Herde bestimmt die Variabilität der zeitlichen Dynamik des Krankheitsprozesses den natürlichen Krankheitsverlauf, der beim individuellen Patienten nicht vorhersagbarist. Dennoch ist es für das Verständnis der Erkrankung und insbesondere für die praktische Betreuung der Patienten ungemein wichtig, sowohl das Spektrum der möglichen Symptome als auch die Grundsätze des natürlichen Krankheitsverlaufes zu kennen, auch wenn diese scheinbar einem „chaotischen“ Prinzip folgen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acevedo AR, Nava C, Arriada N, Violante A, Corona T (2000) Cardiovascular dysfunction in multiple sclerosis. Acta Neurol Scand 101:85–88
Amato MP, Ponziani G, Bartolozzi ML, Siracusa G (1999) A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. J Neurol Sci 168:96–106
Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE, Murray TJ (1994) Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 58:89–93
Broggi G, Ferroli P, Franzini A, Pluderi M, La Mantia L, Milanese C (1999) Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet 354:1878–1879
Bronnum-Hansen H, Koch-Henriksen N, Hyllested K (1994) Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey. Neurology 44:1901–1907
Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339:285–291
Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122:625–639
Ebers G (1998) Natural history of multiple sclerosis. In Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds) McAlpine’s Multiple Sclerosis, 3rd edn. Churchill Livingstone, London, pp 191–221
Filippi M, Tortorella C, Rovaris M, Bozzali M, Possa F, Sormani MP, Iannucci G, Comi G (2000) Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 68:157–161
Fischer JS, Rudick RA, Cutter GR, Reingold SC (1999) The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler 5:244–250
Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH (1997) Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology 49:1142–1144
Gayou A, Brochet B, Dousset V (1997) Transitional progressive multiple sclerosis: a clinical and imaging study. J Neurol Neurosurg Psychiatry 63:396–398
Ghezzi A, Montanini R, Basso PF, Zaffaroni M, Massimo E, Cazzullo CL (1990) Epilepsy in multiple sclerosis. Eur Neurol 30:218–223
Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long-term follow-up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148–152
Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 122:1941–1950
Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1422–1427
Kurtzke JF, Beebe GW, Nagler B, Auth TL, Kurland LT, Nefzger MD (1973) Studies on the natural history of multiple sclerosis. 7. Correlates of clinical change in an early bout. Acta Neurol Scand 49:379–395
Lauer K, Firnhaber W (1992) Prognostic criteria in an epidemiological group of patientswith multiple sclerosis: an exploratory study. J Neurol 239:93–97
Lucchinetti CF, Brück W, Rodriguez M, Lassmann H (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6:259–274
Mattson D, Petrie M, Srivastava DK, McDermott M (1995) Multiple sclerosis. Sexual dysfunction and its response to medications. Arch Neurol 52:862–868
McAlpine D, Compston ND (1952) Some aspects of the natural history of disseminated sclerosis. Q J Med 21:135–167
Miller DH, Hornabrook RW, Purdie G (1992) The natural history of multiple sclerosis: a regional study with some longitudinal data. J Neurol Neurosurg Psychiatry 55:341–346
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
Poser S, Kurtzke JF, Poser W, Schlaf G (1989) Survival in multiple sclerosis. J Clin Epidemiol 42:159–168
Poser S, Liier W, Bruhn H, Frahm J, Brück Y, Felgenhauer K (1992) Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 86:579–585
Poser S, Raun NE, Poser W (1982) Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 66:355–362
Ramirez-Lassepas M, Tulloch JW, Quinones MR, Snyder BD (1992) Acute radicular pain as a presenting symptom in multiple sclerosis. Arch Neurol 49:255–258
Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991a) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–691
Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F (1991b) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692–696
Runmarker B, Andersen O (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116:117–134
Runmarker B, Andersen O (1995) Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118:253–261
Sadovnick AD, Eisen K, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196
Söderström M, Ya-Ping J, Hillert J, Link H (1998) Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50:708–714
Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, Montalban X, De Sá J (1997) Primary progressive multiple sclerosis. Brain 120:1085–1096
Tourbah A, Stievenart JL, Gout O, Fontaine B, Liblau R, Lubetzki C, Cabanis EA, Lyon-Caen O (1999) Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis. Neurology 53:1091–1097
Tranchant C, Bhatia KP, Marsden CD (1995) Movement disorders in multiple sclerosis. Mov Disord 10:418–423
Tumani H, Tourtellotte WW, Peter JB, Felgenhauer K (1998) Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group. J Neurol Sci 155:44–49
Vieregge P, Klostermann W, Brückmann H (1992) Parkinsonism in multiple sclerosis. Mov Disord 7:380–382
Weinshenker BG (1995) The natural history of multiple sclerosis. Neurol Clin 13:119–146
Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112:133–146
Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112:1419–1428
Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1991) The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 114:1045–1056
Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfìgli L, Morassi P, Iona LG, Cazzato G (1999) Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 5:418–427
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bitsch, A. (2001). Klinische Symptomatik und natürlicher Krankheitsverlauf der Multiplen Sklerose. In: Zettl, U.K., Mix, E. (eds) Multiple Sklerose. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59453-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-59453-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41121-5
Online ISBN: 978-3-642-59453-3
eBook Packages: Springer Book Archive